Shari Annes | Investor Relations |
Rachel King | Chief Executive Officer |
Brian Hahn | Senior Vice President and Chief Financial Officer |
Helen Thackray | Senior Vice President-Development and Chief Medical Officer |
Nirav Shelat | Piper Jaffray |
Ritu Baral | Cowen |
Stephen Willey | Stifel |
Ed White | H.C. Wainwright |
Good morning, and thank you for joining the GlycoMimetics call. [Operator Instructions] I would now like to turn the call over to Shari Annes of the Investor Relations Group at GlycoMimetics. Ma’am, please go ahead.
Good morning. Today, we will highlight the key developments of 2019’s Third Quarter.